Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$117.76 USD
+0.50 (0.43%)
Updated Nov 22, 2024 04:00 PM ET
After-Market: $117.74 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 1/22/25 |
---|---|
Current Quarter | 1.34 |
EPS Last Quarter | 1.21 |
Last EPS Surprise | 0.83% |
ABR | 1.58 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.67 |
Next Year | 5.14 |
EPS (TTM) | 4.52 |
P/E (F1) | 25.21 |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.03B | 10.62B | 42.01B | 44.91B |
# of Estimates | 8 | 6 | 8 | 8 |
High Estimate | 11.10B | 10.71B | 42.08B | 45.04B |
Low Estimate | 10.90B | 10.50B | 41.87B | 44.72B |
Year ago Sales | 10.24B | 9.96B | 40.11B | 42.01B |
Year over Year Growth Est. | 7.71% | 6.55% | 4.73% | 6.90% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.34 | 1.12 | 4.67 | 5.14 |
# of Estimates | 9 | 5 | 10 | 10 |
Most Recent Consensus | 1.34 | 1.10 | 4.67 | 5.16 |
High Estimate | 1.34 | 1.20 | 4.68 | 5.16 |
Low Estimate | 1.33 | 1.09 | 4.66 | 5.10 |
Year ago EPS | 1.19 | 0.98 | 4.44 | 4.67 |
Year over Year Growth Est. | 12.61% | 14.29% | 5.18% | 10.02% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 7 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 1 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.34 | 1.12 | 4.67 | 5.14 |
7 Days Ago | 1.34 | 1.12 | 4.67 | 5.14 |
30 Days Ago | 1.34 | 1.12 | 4.67 | 5.14 |
60 Days Ago | 1.34 | 1.12 | 4.66 | 5.13 |
90 Days Ago | 1.34 | 1.12 | 4.66 | 5.13 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.34 | 1.12 | 4.67 | 5.14 |
Zacks Consensus Estimate | 1.34 | 1.12 | 4.67 | 5.14 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.21 | 1.14 | 0.98 | 1.19 | NA |
Estimate | 1.20 | 1.10 | 0.96 | 1.19 | NA |
Difference | 0.01 | 0.04 | 0.02 | 0.00 | 0.02 |
Surprise | 0.83% | 3.64% | 2.08% | 0.00% | 1.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more